Current status of MALDI-TOF mass spectrometry in clinical microbiology

Tsung Yun Hou, Chuan Chiang-Ni, Shih Hua Teng

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Mass spectrometry (MS) is a type of analysis used to determine what molecules make up a sample, based on the mass spectrum that are created by the ions. Mass spectrometers are able to perform traditional target analyte identification and quantitation; however, they may also be used within a clinical setting for the rapid identification of bacteria. The causative agent in sepsis is changed over time, and clinical decisions affecting the management of infections are often based on the outcomes of bacterial identification. Therefore, it is essential that such identifications are performed quickly and interpreted correctly. Matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometer is one of the most popular MS instruments used in biology, due to its rapid and precise identification of genus and species of an extensive range of Gram-negative and -positive bacteria. Microorganism identification by Mass spectrometry is based on identifying a characteristic spectrum of each species and then matched with a large database within the instrument. The present review gives a contemporary perspective on the challenges and opportunities for bacterial identification as well as a written report of how technological innovation has advanced MS. Future clinical applications will also be addressed, particularly the use of MALDI-TOF MS in the field of microbiology for the identification and the analysis of antibiotic resistance.

Original languageEnglish
Pages (from-to)404-414
Number of pages11
JournalJournal of Food and Drug Analysis
Volume27
Issue number2
DOIs
Publication statusPublished - Apr 1 2019

Fingerprint

matrix-assisted laser desorption-ionization mass spectrometry
microbiology
Microbiology
Mass Spectrometry
Lasers
mass spectrometry
spectrometers
sepsis (infection)
Inventions
bacteria
desorption
antibiotic resistance
ionization
lasers
Gram-Positive Bacteria
Microbial Drug Resistance
Gram-Negative Bacteria
ions
Sepsis
microorganisms

Keywords

  • Antibiotic susceptibility testing
  • MALDI-TOF MS
  • Mass spectrometry
  • Microbiology
  • Microorganism identification

ASJC Scopus subject areas

  • Food Science
  • Pharmacology

Cite this

Current status of MALDI-TOF mass spectrometry in clinical microbiology. / Hou, Tsung Yun; Chiang-Ni, Chuan; Teng, Shih Hua.

In: Journal of Food and Drug Analysis, Vol. 27, No. 2, 01.04.2019, p. 404-414.

Research output: Contribution to journalReview article

Hou, Tsung Yun ; Chiang-Ni, Chuan ; Teng, Shih Hua. / Current status of MALDI-TOF mass spectrometry in clinical microbiology. In: Journal of Food and Drug Analysis. 2019 ; Vol. 27, No. 2. pp. 404-414.
@article{e7da828daec0442d95b5ceb7656edd18,
title = "Current status of MALDI-TOF mass spectrometry in clinical microbiology",
abstract = "Mass spectrometry (MS) is a type of analysis used to determine what molecules make up a sample, based on the mass spectrum that are created by the ions. Mass spectrometers are able to perform traditional target analyte identification and quantitation; however, they may also be used within a clinical setting for the rapid identification of bacteria. The causative agent in sepsis is changed over time, and clinical decisions affecting the management of infections are often based on the outcomes of bacterial identification. Therefore, it is essential that such identifications are performed quickly and interpreted correctly. Matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometer is one of the most popular MS instruments used in biology, due to its rapid and precise identification of genus and species of an extensive range of Gram-negative and -positive bacteria. Microorganism identification by Mass spectrometry is based on identifying a characteristic spectrum of each species and then matched with a large database within the instrument. The present review gives a contemporary perspective on the challenges and opportunities for bacterial identification as well as a written report of how technological innovation has advanced MS. Future clinical applications will also be addressed, particularly the use of MALDI-TOF MS in the field of microbiology for the identification and the analysis of antibiotic resistance.",
keywords = "Antibiotic susceptibility testing, MALDI-TOF MS, Mass spectrometry, Microbiology, Microorganism identification",
author = "Hou, {Tsung Yun} and Chuan Chiang-Ni and Teng, {Shih Hua}",
year = "2019",
month = "4",
day = "1",
doi = "10.1016/j.jfda.2019.01.001",
language = "English",
volume = "27",
pages = "404--414",
journal = "Journal of Food and Drug Analysis",
issn = "1021-9498",
publisher = "Elsevier Taiwan LLC",
number = "2",

}

TY - JOUR

T1 - Current status of MALDI-TOF mass spectrometry in clinical microbiology

AU - Hou, Tsung Yun

AU - Chiang-Ni, Chuan

AU - Teng, Shih Hua

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Mass spectrometry (MS) is a type of analysis used to determine what molecules make up a sample, based on the mass spectrum that are created by the ions. Mass spectrometers are able to perform traditional target analyte identification and quantitation; however, they may also be used within a clinical setting for the rapid identification of bacteria. The causative agent in sepsis is changed over time, and clinical decisions affecting the management of infections are often based on the outcomes of bacterial identification. Therefore, it is essential that such identifications are performed quickly and interpreted correctly. Matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometer is one of the most popular MS instruments used in biology, due to its rapid and precise identification of genus and species of an extensive range of Gram-negative and -positive bacteria. Microorganism identification by Mass spectrometry is based on identifying a characteristic spectrum of each species and then matched with a large database within the instrument. The present review gives a contemporary perspective on the challenges and opportunities for bacterial identification as well as a written report of how technological innovation has advanced MS. Future clinical applications will also be addressed, particularly the use of MALDI-TOF MS in the field of microbiology for the identification and the analysis of antibiotic resistance.

AB - Mass spectrometry (MS) is a type of analysis used to determine what molecules make up a sample, based on the mass spectrum that are created by the ions. Mass spectrometers are able to perform traditional target analyte identification and quantitation; however, they may also be used within a clinical setting for the rapid identification of bacteria. The causative agent in sepsis is changed over time, and clinical decisions affecting the management of infections are often based on the outcomes of bacterial identification. Therefore, it is essential that such identifications are performed quickly and interpreted correctly. Matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometer is one of the most popular MS instruments used in biology, due to its rapid and precise identification of genus and species of an extensive range of Gram-negative and -positive bacteria. Microorganism identification by Mass spectrometry is based on identifying a characteristic spectrum of each species and then matched with a large database within the instrument. The present review gives a contemporary perspective on the challenges and opportunities for bacterial identification as well as a written report of how technological innovation has advanced MS. Future clinical applications will also be addressed, particularly the use of MALDI-TOF MS in the field of microbiology for the identification and the analysis of antibiotic resistance.

KW - Antibiotic susceptibility testing

KW - MALDI-TOF MS

KW - Mass spectrometry

KW - Microbiology

KW - Microorganism identification

UR - http://www.scopus.com/inward/record.url?scp=85061016562&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061016562&partnerID=8YFLogxK

U2 - 10.1016/j.jfda.2019.01.001

DO - 10.1016/j.jfda.2019.01.001

M3 - Review article

C2 - 30987712

AN - SCOPUS:85061016562

VL - 27

SP - 404

EP - 414

JO - Journal of Food and Drug Analysis

JF - Journal of Food and Drug Analysis

SN - 1021-9498

IS - 2

ER -